Unique ID issued by UMIN | UMIN000045438 |
---|---|
Receipt number | R000051877 |
Scientific Title | CARTO FINDER mapping comparison study of spontaneous atrial fibrillation and induced atrial fibrillation for persistent atrial fibrillation |
Date of disclosure of the study information | 2021/09/10 |
Last modified on | 2025/02/04 17:30:04 |
CARTO FINDER mapping comparison study of spontaneous atrial fibrillation and induced atrial fibrillation for persistent atrial fibrillation
CARTO FINDER mapping comparison study of spontaneous atrial fibrillation and induced atrial fibrillation for persistent atrial fibrillation
CARTO FINDER mapping comparison study of spontaneous atrial fibrillation and induced atrial fibrillation for persistent atrial fibrillation
CARTO FINDER mapping comparison study of spontaneous atrial fibrillation and induced atrial fibrillation for persistent atrial fibrillation
Japan |
Atrial fibrillation
Cardiology |
Others
NO
To compare and verify the CARTO FINDER mapping of spontaneous atrial fibrillation and induced atrial fibrillation in patients with persistent atrial fibrillation.
Efficacy
Confirmatory
Pragmatic
Not applicable
Comparison of local atrial fibrillation origins identified by a new 3D mapping algorithm
Comparison of local atrial fibrillation origins identified by a novel 3D mapping algorithm at the time of recurrence
Observational
20 | years-old | <= |
85 | years-old | >= |
Male and Female
1) Patients who have given written consent to this study
2) Patients aged 18 to 85
3) Patients with persistent atrial fibrillation with a duration of 1 week or more and who desire drug resistance or catheter ablation
1) Patients who cannot undergo catheter ablation due to anticoagulant therapy or intracardiac thrombosis
2) Patients who are unable to return to sinus rhythm Patients with a history of ablation for atrial fibrillation or atypical atrial flutter.
3) Patients after the Maze procedure.
4) Patients undergoing implantable cardiac device (pacemaker, ICD) treatment.
5) Patients who have taken amiodarone within the past year.
6) Untreated hyperthyroidism or hypothyroidism.
7) Patients with end-stage renal disease (patients with eGFR less than 15 or requiring dialysis therapy).
8) Other patients who the doctor judged not to be indicated for this study (patients who are anatomically considered to be difficult to use CARTO FINDER)
80
1st name | Morio |
Middle name | |
Last name | Ono |
Showa University Northern Yokohama Hospital
Cardiology
224-8503
35-1,chigasakichuuou, yokohamashitudukiku,kanagawa
(+81)45-949-7000
morio.ono@gmail.com
1st name | Morio |
Middle name | |
Last name | Ono |
Showa University Northern Yokohama Hospital
Cardiology
224-8503
35-1,chigasakichuuou, yokohamashitudukiku,kanagawa
(+81)45-949-7000
morio.ono@gmail.com
Department of Cardiology University Northern Yokohama Hospital
none
Self funding
Department of Cardiology University Northern Yokohama Hospital
35-1,chigasakichuuou, yokohamashitudukiku,kanagawa
(+81)45-949-7000
morio.ono@gmail.com
NO
昭和大学横浜市北部病院(神奈川県)
2021 | Year | 09 | Month | 10 | Day |
Unpublished
Completed
2021 | Year | 09 | Month | 08 | Day |
2021 | Year | 08 | Month | 23 | Day |
2021 | Year | 09 | Month | 09 | Day |
2023 | Year | 09 | Month | 10 | Day |
finish
2021 | Year | 09 | Month | 09 | Day |
2025 | Year | 02 | Month | 04 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000051877